Real-time enrollment status for this pmm2-cdg clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT06892288 |
| Recruiting Status | Active, Not Recruiting |
| Condition | PMM2-CDG |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Glycomine, Inc. |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06892288 is currently active_not_recruiting participants. This clinical trial study for pmm2-cdg is not currently accepting new participants at 4 locations across the United States. The study is sponsored by Glycomine, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06892288 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06892288 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.